TVD 2016

Selective nodal irradiation in NSCLC: FDG-PET-CT based!

I 44 patients NSCLC I 61 2-64 8 Gy (1 8 Gy BID) . . . I median FU: 16 months I Isolated nodal recurrence: 1 patient (2.3%)

I 88 patients NSCLC I dose-escalation study

I median FU: 16 months

I Isolated nodal recurrence: 2 patients (2.3%)

Selective nodal irradiation based on PET-CT is safe in NSCLC

De Ruysscher et al ., IJROBP 2005 Belderbos et al ., IJROBP 2006

www.uniklinikum-dresden.de 11